Peptide Basics
What Are Research Peptides? What “Research Use Only” Means on a Label
“Research peptides” are peptides sold with a label such as “for research use only” or “not for human consumption”. The label states what the seller says the product is for; it is not an approval. This page sets out where research-use wording comes from in US regulations, how FDA decides what a product is intended for, what FDA and Australia’s TGA have said about research-use labels on peptides, and how EU and UK law define a medicine — each from the regulator’s own text, with the date we read it. Not legal advice.
The short answer
- “Research peptide” is a market term, not a legal category. None of the FDA, EU, UK or Australian rules cited here defines it. The same molecule can be an approved medicine in one product and an unapproved research chemical in another.
- In US rules, “research use only” is diagnostics wording. 21 CFR 809.10 prescribes it for in vitro diagnostic products still in the laboratory research phase. The rule for drugs, 21 CFR 312.160, uses a different caution and adds conditions on who receives the drug and what records are kept.
- FDA judges intended use by the evidence, not the label alone. Under 21 CFR 201.128 intent can be shown by labeling claims, advertising, statements and the circumstances of distribution.
- FDA and TGA have both addressed the disclaimer directly. FDA warning letters of 2025 and 2026 called peptides sold with research-use statements unapproved new drugs; TGA wrote in April 2026 that the disclaimer does not make supply lawful.
- The label says nothing about approval or quality. Approval is recorded in each regulator’s register; our compound guides give that record, dated, for 55 compounds.
Where research-use wording comes from in US regulations
Three FDA regulations prescribe research or investigational labels word for word. Each covers a defined kind of product and shipment.
| Regulation | Required statement | What it covers |
|---|---|---|
| 21 CFR 809.10(c)(2)(i) | “For Research Use Only. Not for use in diagnostic procedures.” | An in vitro diagnostic product in the laboratory research phase of development, not represented as an effective diagnostic product. |
| 21 CFR 809.10(c)(2)(ii) | “For Investigational Use Only. The performance characteristics of this product have not been established.” | An in vitro diagnostic product shipped for product testing before full commercial marketing. |
| 21 CFR 312.160(a)(1)(i) | “CAUTION: Contains a new drug for investigational use only in laboratory research animals, or for tests in vitro. Not for use in humans.” | A drug intended solely for tests in vitro or in animals used only for laboratory research. The shipper must use due diligence to assure the consignee regularly conducts such tests, and keep records of each shipment for two years. |
FDA’s guidance “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only” (November 2013) sets out the agency’s thinking on when diagnostic products are properly labeled with the first two statements. Under 312.160, FDA may end the authorization to ship if the drug is used for purposes other than bona fide scientific investigation, and when the investigation ends the shipper must arrange for unused supplies to be returned from the investigators, or authorize in writing another disposition that does not expose humans to risk.
Source: Electronic Code of Federal Regulations, title 21, sections 809.10, 312.160 and 201.128 (point-in-time text for 26 October 2026), and FDA’s guidance page (docket FDA-2011-D-0305, page current as of 20 February 2018), read 28 October 2026.
How FDA decides what a product is intended for
Whether an article is a drug turns on its intended use, and 21 CFR 201.128 defines that as the objective intent of the persons legally responsible for its labeling. The regulation says this intent may be shown by their expressions, by the design or composition of the article, or by the circumstances surrounding its distribution — for example labeling claims, advertising matter, or oral or written statements. It may also be shown where the article is, with their knowledge, offered or used for a purpose for which it is neither labeled nor advertised.
The same section adds that intended uses can change after an article leaves its manufacturer: a distributor or seller who intends it for different uses must supply labeling for those uses.
What FDA warning letters say about research-use labels on peptides
26 February 2025 (MARCS-CMS 696885). FDA wrote to an online seller of semaglutide and tirzepatide products that, despite statements on its labeling and website such as “research use only,” “not for human consumption,” “lab purposes only” and “not intended to diagnose, cure, mitigate, treat or prevent disease,” evidence from the website established that the products were drugs intended for human use. It quoted the product pages as that evidence, under 21 CFR 201.128, and called the products unapproved new drugs and misbranded drugs.
17 June 2026 (reference 729447). FDA wrote to a seller of gonadorelin and a product sold as Prostamax that, despite labeling marketing the products for “RESEARCH USE ONLY” and “not for human consumption,” evidence from the product labeling, including the website, established that they were intended to be drugs for human use, and called them unapproved new drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act.
Both letters describe what FDA found on those sellers’ websites; neither is a general rule, and FDA states that its letters are not all-inclusive lists of violations.
Source: FDA warning letters, published at fda.gov under Warning Letters (pages current as of 11 March 2025 and 23 June 2026), read 28 October 2026.
Australia: TGA’s safety advisory of April 2026
TGA’s advisory on importing, compounding and supplying unapproved peptide products (published 13 April 2026) says peptide products are regulated as therapeutic goods under the Therapeutic Goods Act 1989, and that unapproved peptide products are goods not included in the Australian Register of Therapeutic Goods (ARTG). It names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples and says TGA has not assessed such products for safety, quality or effectiveness.
On labels, the advisory says a disclaimer that a product is for “research use only” does not make its supply lawful, and that such disclaimers alone do not change a product’s regulatory status, permit importation, or remove advertising or supply obligations. It adds that state and territory laws may impose further controls, and that product labelling on unapproved peptides may be inaccurate or misleading.
Source: TGA, “Understanding your responsibilities when importing, compounding and supplying unapproved peptide products”, safety advisory published 13 April 2026, read 28 October 2026 (from the Internet Archive copy; tga.gov.au did not respond that day).
European Union and United Kingdom: how a medicine is defined
EU law (Directive 2001/83/EC, Article 1(2)) and UK law (Human Medicines Regulations 2012, regulation 2) define a medicinal product in two limbs: any substance presented as having properties for treating or preventing disease in human beings; or any substance that may be used in or administered to human beings to restore, correct or modify physiological functions by a pharmacological, immunological or metabolic action, or to make a medical diagnosis. Neither definition refers to a research-use label.
The phrase itself appears in the EU’s diagnostics regulation. Regulation (EU) 2017/746, Article 1(3)(a), excludes “products for general laboratory use or research-use only products” from its scope, unless their manufacturer specifically intends them, in view of their characteristics, for in vitro diagnostic examination.
Source: EUR-Lex consolidated texts of Directive 2001/83/EC (1 January 2025) and Regulation (EU) 2017/746 (10 January 2025); legislation.gov.uk, SI 2012/1916 regulation 2. Read 28 October 2026.
What a research-use label does not tell you
It does not tell you whether any regulator has approved a product containing the peptide: that is recorded in Drugs@FDA, EMA’s medicines data, the MHRA products register and the ARTG, and our Are Peptides Legal? page links each compound guide’s dated table. It does not tell you what the vial contains: TGA’s advisory notes that for unapproved peptides, how they are made, whether they are sterile and what they actually contain remain unknown. And it draws no line for anyone else: whether a particular sale, import, purchase or use is lawful depends on facts and laws outside these records, and needs a qualified lawyer.
Medibact does not sell peptides. We supply USP-grade bacteriostatic water, made in the USA, for research use only, and publish reference material like this page.
Where this sits in the rest of the reference
FAQ
What are research peptides?
“Research peptides” is a market term for peptides sold with a label such as “for research use only” or “not for human consumption”, for example BPC-157, TB-500 or retatrutide. None of the FDA, EU, UK or Australian rules cited here uses it as a category. The label states the seller's intended use; it is not an approval, and the same molecule can be an approved medicine in one product and an unapproved research chemical in another.
What does “research use only” mean?
In US regulations the exact wording comes from diagnostics: 21 CFR 809.10 requires “For Research Use Only. Not for use in diagnostic procedures.” on an in vitro diagnostic product that is still in the laboratory research phase. For drugs, the nearest rule is 21 CFR 312.160, which lets a new drug be shipped solely for laboratory research in animals or in vitro tests under a caution label ending “Not for use in humans”, with due diligence about who receives it and records of every shipment.
Does a “research use only” label mean a peptide is approved or legal?
No regulator in our records treats the label as an approval. FDA approvals are listed in Drugs@FDA, and a research-use label does not put a product there. Australia's TGA wrote on 13 April 2026 that such disclaimers do not make supply lawful and do not, on their own, change a product's regulatory status, permit importation, or remove advertising or supply obligations. Whether a particular sale or use is lawful depends on facts and laws this page does not assess.
Is “not for human consumption” different from “research use only”?
Both describe the seller's stated intended use, and FDA has addressed them together. In a warning letter of 26 February 2025, FDA listed “research use only,” “not for human consumption,” “lab purposes only” and “not intended to diagnose, cure, mitigate, treat or prevent disease” and stated that, despite these statements, evidence from the seller's website established that the products were drugs intended for human use.
How does FDA decide what a product is intended for?
Under 21 CFR 201.128, intended use means the objective intent of the people responsible for the labeling. FDA says it may be shown by their expressions, the design or composition of the article, or the circumstances of its distribution, for example labeling claims, advertising, or oral or written statements, and by circumstances in which the article is knowingly offered or used for a purpose for which it is neither labeled nor advertised.
Has FDA acted against peptides labelled for research use?
Yes. FDA's published warning letters include one of 26 February 2025 about semaglutide and tirzepatide products and one of 17 June 2026 about gonadorelin and a product sold as Prostamax, both sold with research-use statements. In each, FDA cited the sellers' own product pages as evidence that the products were drugs and called them unapproved new drugs. FDA posts its warning letters on fda.gov.
What does Australia's TGA say about research peptides?
In a safety advisory published 13 April 2026, TGA said peptide products are regulated as therapeutic goods under the Therapeutic Goods Act 1989, and that unapproved peptide products are those not included in the Australian Register of Therapeutic Goods. It named BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples, said it has not assessed them for safety, quality or effectiveness, and said a research-use-only disclaimer does not make supply lawful.
How do the EU and UK define a medicine?
Directive 2001/83/EC and the UK Human Medicines Regulations 2012 define a medicinal product in two limbs: a substance presented as having properties for treating or preventing disease in human beings, or one that may be used in or administered to human beings to restore, correct or modify physiological functions by a pharmacological, immunological or metabolic action, or to make a medical diagnosis. Neither definition refers to a research-use label. In EU law the phrase “research-use only” appears in the diagnostics regulation, Regulation (EU) 2017/746.
Is this legal advice?
No. This page reports what regulators' own rules and published records say, with the date each was read. It draws no conclusion about what any person may buy, import, possess or use, and does not cover state or national law beyond the records cited. For that, ask a qualified lawyer. Medibact does not sell peptides and is not affiliated with any company named in the records cited here.
Not legal advice. References: 21 CFR 809.10, 312.160 and 201.128; FDA warning letters of 26 February 2025 and 17 June 2026; TGA safety advisory of 13 April 2026; Directive 2001/83/EC; Regulation (EU) 2017/746; Human Medicines Regulations 2012. All read 28 October 2026.
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.